REQUEST A DEMO
Total
USD $0.00
Search more companies

Takeda Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Takeda Pharma Sp. z o.o. Profile Updated: March 26, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Nycomed Pharma Sp. z o. o. manufactures, distributes and sales medicine and dietary supplements. The company ownes a manufacturing facility in Lyszkowice The drugs are produced for domestic and foreigh markets, including Germany, Spain, Italy, Netherlands, Canada and Arab countries.

Headquarters
Ul. Prosta 68
Warsaw; Mazowieckie; Postal Code: 00-838

Contact Details: Purchase the Takeda Pharma Sp. z o.o. report to view the information.

Website: http://www.takeda.com.pl

Basic Information
Total Employees:
Purchase the Takeda Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Takeda Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Takeda Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Takeda Pharma Sp. z o.o. report to view the information.
Ratings:
Purchase the Takeda Pharma Sp. z o.o. report to view the information.
Incorporation Date:
November 19, 2001
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Shire Polska Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Takeda Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-17.4%
Total operating revenue
-17.37%
Operating profit (EBIT)
-11.57%
EBITDA
-8.85%
Net Profit (Loss) for the Period
11.06%
Total assets
47.47%
Total equity
41.04%
Operating Profit Margin (ROS)
0.38%
Net Profit Margin
1.13%
Return on Equity (ROE)
-1.38%
Quick Ratio
0.43%
Cash Ratio
0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?